Phibro Animal Health CorporationPAHCNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR-9.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-9.0%/yr
Quarterly compound
Percentile
P82
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 9.03% |
| Q3 2025 | -6.34% |
| Q2 2025 | 7.37% |
| Q1 2025 | -6.92% |
| Q4 2024 | 16.02% |
| Q3 2024 | -4.27% |
| Q2 2024 | 15.18% |
| Q1 2024 | -5.15% |
| Q4 2023 | -8.09% |
| Q3 2023 | 29.40% |
| Q2 2023 | -7.17% |
| Q1 2023 | -7.40% |
| Q4 2022 | 11.97% |
| Q3 2022 | -1.04% |
| Q2 2022 | 5.92% |
| Q1 2022 | 8.38% |
| Q4 2021 | -3.37% |
| Q3 2021 | -1.19% |
| Q2 2021 | 3.34% |
| Q1 2021 | 1.36% |
| Q4 2020 | -0.12% |
| Q3 2020 | 14.10% |
| Q2 2020 | -12.00% |
| Q1 2020 | -2.55% |
| Q4 2019 | 4.16% |
| Q3 2019 | -10.68% |
| Q2 2019 | 25.76% |
| Q1 2019 | -1.48% |
| Q4 2018 | -0.03% |
| Q3 2018 | 3.75% |
| Q2 2018 | -2.76% |
| Q1 2018 | -0.94% |
| Q4 2017 | 4.84% |
| Q3 2017 | 3.52% |
| Q2 2017 | 29.22% |
| Q1 2017 | -25.02% |
| Q4 2016 | 4.30% |
| Q3 2016 | -0.79% |
| Q2 2016 | 1.85% |
| Q1 2016 | -2.54% |